<prompt> Tyrosine kinase inhibitor with HER2NEU receptor inhibition propey?ImatinibNilotinibLapatinibSunitinib  <response>: Lapatinib has both the actions and active against breast cancer cells it is an EGFR inhibitor. Ref: KK Sharma 3rd ed. Pg: 870 